{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T16:31:29Z","timestamp":1761323489302},"reference-count":14,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1990,11,1]],"date-time":"1990-11-01T00:00:00Z","timestamp":657417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":9167,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[1990,11]]},"DOI":"10.1038\/ki.1990.291","type":"journal-article","created":{"date-parts":[[2007,5,28]],"date-time":"2007-05-28T17:47:09Z","timestamp":1180374429000},"page":"919-924","source":"Crossref","is-referenced-by-count":30,"title":["Effects of recombinant human erythropoietin on cerebral and cutaneous blood flow and on blood coagulability"],"prefix":"10.1016","volume":"38","author":[{"given":"William J.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James T.","family":"Mccarthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiko","family":"Yanagihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip J.","family":"Osmundson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duane M.","family":"Ilstrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernice M.","family":"Jenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. J. Walter","family":"Bowie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/ki.1990.291_bb0010","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1021\/bi00383a034","article-title":"Characterization of recombinant human erythropoietin produced in Chinese hamster ovary cells","volume":"26","author":"Davis","year":"1987","journal-title":"Biochemistry"},{"key":"10.1038\/ki.1990.291_bb0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM198701083160203","article-title":"Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: Results of a combined phase I and II clinical trial","volume":"316","author":"Eschbach","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.1990.291_bb0020","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(86)92192-6","article-title":"Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis","volume":"2","author":"Winearls","year":"1986","journal-title":"Lancet"},{"key":"10.1038\/ki.1990.291_bb0025","first-page":"193","article-title":"Transfusional iron overload in patients undergoing dialysis: Treatment with erythropoietin and phlebotomy","volume":"114","author":"McCarthy","year":"1989","journal-title":"J Lab Clin Med"},{"key":"10.1038\/ki.1990.291_bb0030","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0025-6196(12)62692-5","article-title":"Effect of arterial revascularization on transcutaneous oxygen tension of the ischemic extremity","volume":"63","author":"Osmundson","year":"1988","journal-title":"Mayo Clin Proc"},{"key":"10.1038\/ki.1990.291_bb0035","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/01.STR.15.5.816","article-title":"Cerebral blood flow measurement in cerebrovascular occlusive diseases","volume":"15","author":"Yanagihara","year":"1984","journal-title":"Stroke"},{"key":"10.1038\/ki.1990.291_bb0040","series-title":"Rheology of Blood in Diagnostic and Preventive Medicine: An Introduction to Clinical Haemorpheology","first-page":"54","author":"Dintenfass","year":"1976"},{"key":"10.1038\/ki.1990.291_bb0045","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0002-9343(88)80025-1","article-title":"Plasma and platelet von Willebrand factor defects in uremia","volume":"85","author":"Gralnick","year":"1988","journal-title":"Am J Med"},{"key":"10.1038\/ki.1990.291_bb0050","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/ki.1985.119","article-title":"Regional cerebral blood flow in dialysis encephalopathy and primary degenerative dementia","volume":"28","author":"Mathew","year":"1985","journal-title":"Kidney Int"},{"key":"10.1038\/ki.1990.291_bb0055","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1161\/01.CIR.43.6.876","article-title":"Hemodynamics of uremic anemia","volume":"43","author":"Neff","year":"1971","journal-title":"Circulation"},{"key":"10.1038\/ki.1990.291_bb0060","series-title":"Product Information Bulletin","article-title":"Am Gen Corporation: Epogen for injection","year":"1989"},{"key":"10.1038\/ki.1990.291_bb0065","first-page":"238","article-title":"Recombinant human erythropoietin therapy in haemodialysis patients-dose determination and clinical experience","volume":"2","author":"Bommer","year":"1987","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.1990.291_bb0070","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0140-6736(87)91849-6","article-title":"Improvement in the haemostatic defect of uraemia after treatment with recombinant human erythropoietin","volume":"2","author":"Moia","year":"1987","journal-title":"Lancet"},{"key":"10.1038\/ki.1990.291_bb0075","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0049-3848(90)90317-6","article-title":"Recombinant human erythropoietin shortens the uraemic bleeding time without causing intravascular haemostatic activation","volume":"57","author":"Gordge","year":"1990","journal-title":"Thromb Res"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815570361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815570361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T21:29:26Z","timestamp":1635542966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815570361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,11]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1990,11]]}},"alternative-id":["S0085253815570361"],"URL":"https:\/\/doi.org\/10.1038\/ki.1990.291","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[1990,11]]}}}